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Misfolded or unfolded proteins in the ER are said to be degraded only after trans-
location or isolation from the ER. Here, we describe amechanismbywhichmutant
proteins are degraded within the ER. Aggregates of mutant arginine vasopressin
(AVP) precursor were confined to ER-associated compartments (ERACs) con-
nected to the ER in AVP neurons of a mouse model of familial neurohypophysial
diabetes insipidus. The ERACs were enclosed by membranes, an ER chaperone
and marker protein of phagophores and autophagosomes were expressed
around the aggregates, and lysosomes fused with the ERACs. Moreover, lyso-
some-related molecules were present within the ERACs, and aggregate degrada-
tion within the ERACs was dependent on autophagic-lysosomal activity. Thus, we
demonstrate that protein aggregates can be degraded by autophagic-lysosomal
machinery within specialized compartments of the ER.
INTRODUCTION
The ER is an organelle mainly responsible for the synthesis, folding, assembly, and transport of proteins
(Kaufman, 1999). While properly folded proteins are packed into secretory granules as secretory proteins
or transported to the cellular membrane as membrane proteins through the Golgi apparatus (Braakman
and Bulleid, 2011; Gidalevitz et al., 2013), misfolded or unfolded proteins accumulate in the ER causing
ER stress (Hetz, 2012; Schroder and Kaufman, 2005; Wang and Kaufman, 2012). The unfolded protein
response, including ER-associated degradation (ERAD), is a cellular mechanism by which ER stress is
reduced. Through the ERAD machinery, misfolded or unfolded proteins are translocated from the ER to
the cytosol and degraded by the ubiquitin-proteasome system (UPS) (Guerriero and Brodsky, 2012; Qi
et al., 2017; Smith et al., 2011). In addition, a growing body of evidence has accumulated regarding ER-
phagy machinery targeting protein aggregates in the ER lumen that cannot be degraded by ERAD (Fregno
and Molinari, 2018; Smith and Wilkinson, 2017; Song et al., 2018; Wilkinson, 2019). In macro-ER-phagy, an
isolationmembrane called a phagophore sequesters a portion of the ER containing the aggregates to form
an autophagosome, which fuses with a lysosome to degrade the contents (Cunningham et al., 2019; For-
rester et al., 2019; Schultz et al., 2018). Recent studies have also reported another type of ER-phagy, mi-
cro-ER-phagy, in which a lysosome engulfs or fuses with aggregate-containing ER buds independent of au-
tophagosome biogenesis (Fregno et al., 2018; Omari et al., 2018). In either case of ERAD or ER-phagy,
aggregates in the ER are degraded only after translocation or isolation from the ER.
Arginine vasopressin (AVP), an antidiuretic hormone, is synthesized in magnocellular neurons of the supra-
optic nuclei (SON) and paraventricular nuclei (PVN) in the hypothalamus (Bisset and Chowdrey, 1988). The
AVP gene encodes a signal peptide, AVP, the AVP carrier protein neurophysin II (NPII), and a glycoprotein,
also referred to as copeptin (Sausville et al., 1985). Upon removal of the signal peptide, prepro-AVP is trun-
cated to pro-AVP, which is folded into its native conformation in the ER and then is packed into secretory
granules. AVP, NPII, and the glycoprotein are cleaved from pro-AVP in the vesicle during transport to the
posterior pituitary, from which AVP is released into systemic circulation in response to changes in plasma
osmolality and blood pressure (Brownstein et al., 1980; Burbach et al., 2001). AVP is also known to beiScience 23, 101648, October 23, 2020 ª 2020 The Authors.
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Figure 1. SBF-SEM Analysis of the SON from FNDI Mice
(A) Three-dimensional reconstruction of a brain volume obtained from serial electron microscopic images of the SON
from FNDI mice. An AVP neuron (green) is observed on the surface of the block. Scale bars: 5 mm.
(B) Two adjacent AVP neurons (blue and light blue) in the SBF-SEM image which have large electron-dense ERACs
(asterisks, colored red in inset) and surrounding intact rough ER (inset, arrowheads). The boxed region is shown at higher




Articlereleased from dendrites and to modulate the phasic activity of AVP neurons by autocrine regulation in or-
der to maximize AVP secretion efficiency (Ludwig and Leng, 2006; Pow and Morris, 1989).
Familial neurohypophysial diabetes insipidus (FNDI) is an autosomal dominant disease caused by muta-
tions in the AVP gene locus, predominantly in the region encoding NPII (Arima et al., 2016; Babey et al.,
2011; Christensen and Rittig, 2006). We previously generated FNDI model mice by introducing an NPII mu-
tation (that causes FNDI in humans) into the AVP gene locus, and the resulting heterozygous mice recapit-
ulated the phenotypes of patients with FNDI. Owing to AVP deficiency, urine volumes and water intake
were significantly increased, and urine osmolality was significantly reduced in FNDI mice compared with
wild-type mice (Hayashi et al., 2009). In the AVP neurons of FNDI mice, inclusion bodies were present
and increased in size as the mice aged in proportion to the increase in urine volumes (Hayashi et al.,
2009) and decreased in size when the FNDI mice were treated with desmopressin (Hiroi et al., 2010), an
AVP agonist (Edwards et al., 1973). Electron microscopic analyses of AVP neurons in FNDI mice revealed
that aggregates were confined to a specific compartment of the rough ER, termed the ERAC (ER-associ-
ated compartment) (Hagiwara et al., 2014). Despite the presence of massive aggregates in the ER of
AVP neurons in FNDI mice, there was no significant difference in the expression levels of an ER chaperone
immunoglobulin heavy chain binding protein (BiP) in AVP neurons between wild-type and FNDI mice at
3 months of age. This suggests that the pathophysiological significance of ERACs is their ability to maintain
function in the remainder of the ER by sequestering and confining aberrant proteins to the ERAC (Hagiwara
et al., 2014). However, it remains to be elucidated whether ERACs are connected to the intact ER lumen or if
there are any mechanisms by which aggregates are degraded within the ERACs.
In the present study, we hypothesized that aggregates are degraded by lysosomes within the ERACs which
maintain connection to the intact ER lumen. To test this hypothesis, we investigated the following: (1) the struc-
tural relationships between ERACs, ERmembranes, and lysosomes by serial block-face scanning electronmicro-
scopy (SBF-SEM), (2) the localization of several molecules involved in autophagic-lysosomal degradation, as well
as ER chaperones by immunoelectron microscopy, and (3) the pharmacological effects of inducing or inhibiting
the autophagic-lysosomal degradation system on ERAC formation in AVP neurons of FNDI mice.
RESULTS
ERACs Are Connected to the Intact ER Lumen
In order to elucidate the detailed structural relationships between organelles, three-dimensional electron
microscopic analyses were performed by acquiring several sets of serial electron microscopic images from
the SON of FNDI mice using SBF-SEM. Each dataset spanned volumes of approximately 30–50 mm x 30–
40 mm x 16–20 mm at subcellular resolution (Figure 1A). These datasets included SON neurons which2 iScience 23, 101648, October 23, 2020
Figure 2. ERACs Are Connected to the Intact ER Lumen and Lysosomes
(A–E) Serial images of an ERAC (A, red) with multiple small protrusions (A, arrows). The boxed regions in A1-3 are magnified in the inset (A2) or in other panels
(B4 and D3). Magnified serial images of one ERAC protrusion connected to the intact ER lumen (B1-4, B10-40 , arrows). The compartments associated with the
connection are colored red (B10-40). Three-dimensional reconstruction of an ERAC (C, red) and intact ER (C, blue). Magnified serial electron microscopic
ll
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images (D1-12) and 3D reconstruction (E) of one protrusion (D2-9, arrowheads, colored red) connected to an ERAC (partly colored red in D1-3) which is
shown to be connected to the ER in B and C. The tip of the protrusion (D10-12, white arrowheads) exposed to the cytosol is connected to a lysosome (D9-
12, colored purple). A three-dimensional reconstruction of an ERAC (E, red) and a lysosome (E, purple) is shown. The numbers in the upper-right corners
indicate the respective slice within the electron microscopic image stack. Scale bars: 1 mm (A1) and 500 nm (B1, C, D1, and E). See also Figures S1 and S2




Articlepossessed electron-dense ERACs located in their cytosol and surrounded by various organelles including
the rough ER (Figure 1B). Detailed analyses of these serial images showed that the ERACs were enclosed by
membranes of high electron density surrounded by an electron-lucent area and that they frequently had
small protrusions (Figure 2A). Careful tracing revealed that these ERAC-derived protrusions were often
connected to the intact ER lumen (Figures 2A3, 2B1-4, and 2C, and Video S1). A montage image of two
angularly connected electron microscopic images reconstructed from the original serial images also
showed the connection between the ERAC and intact ER lumen (Figure S1). In addition, another protrusion
originating from the ER-connected ERAC was also found connected to electron-dense lysosomes in the
cytosol (Figures 2D and 2E, and Video S2). ERACs containing a relatively small amount of aggregates
were also fused with lysosomes but not via the protrusions (Figure S2, and Videos S3 and S4). These results
suggest that ERACs have direct connections with both the ER lumen and lysosomes in the cytosolic
compartment of AVP neurons and that mutant aggregates in the ER could undergo degradation by lyso-
somes from relatively early stages of ERAC formation.Mutant NPII Is Confined within ERACs of AVP Neurons in FNDI Mice
To distinguish normal from mutant NPII, we used two types of antibodies, as described previously (Ben-
Barak et al., 1984, 1985; Hayashi et al., 2009). In AVP neurons of FNDI mice, immunofluorescence staining
showed that mutant NPII was expressed in round structures; in contrast, there were no normal NPII signals
within these structures (Figures 3A–3C). Immunoelectron microscopy demonstrated that mutant NPII was
expressed in ERACs (Figures 3D and 3E) and in aggregates in the ER lumen (Figure 3G), suggesting that
immunohistochemical staining of mutant NPII in areas other than the round structures represents regions
in the ER where mutant NPII is also present. Mutant NPII was not expressed in the electron-lucent area
around the aggregates (Figure 3D). While our previous study clearly demonstrated that aggregates
were surrounded by membranous structures studded with ribosomes (Morishita et al., 2011), this is less
clear in the immunoelectron microscopic analyses in which the membranous structures may be difficult
to maintain. Normal NPII was found in neurosecretory granules of the cell bodies in AVP neurons and in
the nerve terminals of the posterior pituitary, but not in the ER, in both FNDI (Figures 3F–3I) and wild-
type mice (Figure S3). In contrast, mutant NPII was not observed in either neurosecretory granules or the
nerve terminals of the posterior pituitary in FNDI mice (Figures 3D–3I). These data indicate that mutant
AVP precursors are confined to ERACs and not subjected to proper cellular trafficking out of the ER.ERACs Are Surrounded by Phagophore-like Membranes Derived from the ER
Immunofluorescent signals for BiP appeared to surround the round structures that were positive for mutant
NPII antibodies in AVP neurons of FNDI mice (Figures 4A–4C). Immunoelectron microscopic analyses re-
vealed that BiP was expressed in aggregate-surrounding areas including the electron-lucent regions (Fig-
ures 4D and 4E). Our data, derived using immunoelectron microscopy, also showed that both mutant NPII
(Figure 3G) and BiP (Figure S4) were expressed in the ER of AVP neurons of FNDI mice, suggesting that the
overlapping areas between mutant NPII and BiP immunostaining in areas other than the round structures
likely correspond to the ER. In wild-type mice, BiP was expressed in the ER of AVP neurons (Figures S3A–
S3C). Green fluorescent protein (GFP)–labeled microtubule-associated protein 1 light chain 3 (LC3) was
also observed surrounding these rounded structures that were positively stained with mutant NPII anti-
bodies in the AVP neurons of FNDI/GFP-LC3 mice (Figures 4F–4H) and was also detected around aggre-
gates based on immunoelectron microscopy (Figure 4I). In contrast, immunofluorescent signals for GFP-
LC3 were not visible in AVP neurons of GFP-LC3 mice (Figure S5). These findings suggest that ERACs
are surrounded by membranes characteristic of phagophores derived from the ER.Lysosome-Related Molecules Are Expressed within ERACs
Immunofluorescence images demonstrated that lysosome-associated membrane protein 2 (LAMP2) (Fig-
ures 5A–5C) and cathepsin D (Figures 5D–5F) were localized within the round mutant NPII-positive struc-
tures in AVP neurons of FNDI mice, while these signals were not observed in the AVP neurons of wild-4 iScience 23, 101648, October 23, 2020
Figure 3. Mutant NPII Is Confined within ERACs in AVP Neurons of FNDI Mice
(A–C) Immunofluorescence staining for mutant (green) and normal (magenta) NPII, as well as DAPI (blue) in the SON of FNDI mice. Higher magnification
images of the boxed areas in the left panels are shown at right. Scale bars: 50 mm (left panels) and 10 mm (right panels).
(D–I) Immunoelectron microscopic analysis of mutant NPII (10 nm gold particles) and normal NPII (15 nm gold particles) in AVP neurons from the SON (D–G)
and posterior pituitary (H and I) of FNDI mice. (D) An ERAC and a vesicle containing neurosecretory granules are shown. (G) Aggregates in the ER lumen.
Higher magnification images of the boxed areas in D and H are shown in E, F, and I, respectively. The white arrowheads in F, G, and I indicate neurosecretory
granules containing AVP. m: mitochondria. Scale bars: 100 nm (D, E, F, and I) and 500 nm (G and H).




Articletype mice (Figure S6). Further analyses using immunoelectron microscopy revealed that LAMP2 and
cathepsin D were present inside the ERACs (Figures 5G and 5H) but not in the electron-lucent areas around
the aggregates, suggesting that lysosomes were incorporated into ERACs. Furthermore, the overlap be-
tween mutant NPII and LAMP2 immunostaining in areas other than the round structures suggests that ly-
sosomes also fuse to the ER where relatively small aggregates are found, as shown in Figure S2. On the
other hand, the finding that cathepsin D was preferentially located in the aggregates within ERACs sug-
gests the possibility that lysosomal acid hydrolases including cathepsin D are confined to ERACs and do
not spread into the intact ER lumen.The Accumulation of Aggregates within ERACs Is reduced by the Autophagy Inducer
Rapamycin and Increased by the Lysosome Inhibitor Chloroquine
To examine whether peripheral injection of rapamycin and chloroquine could act on the hypothalamus,
LC3 conversion (LC3-I to LC3-II) in the hypothalamus of wild-type mice injected with rapamycin or chloro-
quine was analyzed by immunoblotting. The LC3-II/LC3-I ratio was increased in the rapamycin groupiScience 23, 101648, October 23, 2020 5
Figure 4. ERACs Are Surrounded by Membranes that Express BiP and LC3
(A–C) Immunofluorescence staining for mutant NPII (green) and BiP (magenta) in the SON of FNDI mice. Higher magnification images of the boxed areas in
the left panels are shown at right. Scale bars: 50 mm (left panels) and 10 mm (right panels).
(D and E) Immunoelectron microscopic analysis for BiP (10 nm gold particles) and normal NPII (15 nm gold particles) in AVP neurons from the SON of FNDI
mice. Higher magnification image of the boxed area in D is shown in E. m: mitochondria, Gol: Golgi apparatus. Scale bars: 500 nm (D) and 100 nm (E).
(F–H) Immunofluorescence staining for GFP-LC3 (green) and mutant NPII (magenta) in the SON of FNDI/GFP-LC3 mice. Higher magnification images of the
boxed areas in the left panels are shown at right. Scale bars: 50 mm (left panels) and 10 mm (right panels).
(I) Immunoelectron microscopic analysis of GFP-LC3 (12 nm gold particles, white arrowheads) in AVP neurons from the SON of FNDI/GFP-LC3 mice. A small
portion of an ERAC is shown. Scale bar: 100 nm.




Articlecompared with the control (Figure S7A), suggesting that autophagic flux was increased in the hypothala-
mus of mice treated with the autophagy inducer rapamycin. The LC3-II/LC3-I ratio was also increased in
the chloroquine group compared with the control (Figure S7B). This is consistent with previous studies
showing that LC3-II, a substitute of autophagic degradation, was increased relative to LC3-I when autopha-
gic degradation was inhibited by the lysosome inhibitor chloroquine (Han et al., 2019).
In FNDI mice, the number of inclusion bodies over 4.5 mm in diameter [the mean size in 3-month-old FNDI
mice (Hagiwara et al., 2014)] was significantly decreased by rapamycin treatment (Figure 6A), while the
number of inclusion bodies was significantly increased by chloroquine administration (Figure 6B).6 iScience 23, 101648, October 23, 2020
Figure 5. Lysosome-Related Molecules Are Expressed within ERACs
(A–F) Immunofluorescence staining for mutant NPII (green) and LAMP2 or cathepsin D (magenta) in the SON of FNDI mice. Higher magnification images of
the boxed areas in the left panels are shown at right. Scale bars: 50 mm (left panels) and 10 mm (right panels).
(G and H) Immunoelectron microscopic analysis of LAMP2 (G, 10 nm gold particles, white arrowheads) or cathepsin D (H, 10 nm gold particles, white
arrowheads) in AVP neurons from the SON of FNDI mice. The large images show a small portion of an ERAC; higher magnification images of the boxed areas
are shown in the insets at lower left. Scale bars: 500 nm.





In the present study, we showed that ERACs, in which mutant NPII was accumulated, were
connected to the intact ER and enclosed by membranes. We also showed that BiP and LC3 were ex-
pressed around the aggregates and that LAMP2 and cathepsin D were present within the ERACs.iScience 23, 101648, October 23, 2020 7
Figure 6. Accumulation of Aggregates within ERACs Is Reduced by the Autophagy Inducer Rapamycin and
Increased by the Lysosome Inhibitor Chloroquine
(A–D) Representative images of immunohistochemical staining for mutant NPII in the SON and the number of inclusion
bodies with a diameter >4.5 mm in the SON of 3-month-old FNDI mice in the control and rapamycin (Rapa, A and B) or
chloroquine (CQ, C and D) or groups. Results are expressed asmeansG SE; n = 5–7 animals per group.White arrowheads
indicate the inclusion bodies. Scale bars: 50 mm.
(E) Possible mechanisms of ERAC formation and mutant NPII degradation in AVP neurons of FNDI mice. Mutant NPII is
confined to the ERACs of AVP neurons in FNDI mice. The ER chaperone BiP was localized around the ERACs, indicating
that ERACs are connected to the ER and that BiP might be associated with ERAC formation. Furthermore, LAMP2 and
cathepsin D were expressed in ERACs surrounded by membranes with LC3, suggesting that lysosomes degrade mutant
NPII within ERACs which are connected to the ER. mNPII: mutant NPII.




ArticleFurthermore, our data showed that the number of ERACs was decreased or increased by
rapamycin or chloroquine treatment, respectively. Figure 6E summarizes the findings of our present




ArticleThe formation of ERAC-like structures has been reported not only in FNDI but also in other diseases, such
as a1-antitrypsin deficiency (Granell et al., 2008), familial encephalopathy with neuroserpin inclusion bodies
(Hagen et al., 2011), seipinopathy (Ito et al., 2012), and autosomal dominant retinitis pigmentosa (Chiang
et al., 2012; Saliba et al., 2002). While previous studies including ours suggested that aggregates were
confined to a subcompartment of the ER, it has been unclear whether there is any communication between
the ER and these compartments. In the present study, we demonstrated that ERACs were connected to the
intact ER lumen using SBF-SEM. Furthermore, our data showed that membranes enclosed the aggregates,
around which an ER chaperone (BiP) was expressed, suggesting that the ERAC membranes were derived
from the ER. As ERAC formation reportedly mitigates ER stress and improves cellular viability not only in
FNDI (Hagiwara et al., 2014) but also in a1-antitrypsin deficiency (Granell et al., 2008), it could be a common
unfolded protein response shared by several cell types for coping with ER stress. Whether aggregates
within ERACs are degraded by autophagic-lysosomal machinery in other diseases remains to be
elucidated.
The finding that mutant NPII was not observed in the neurosecretory granules but was exclusively within
ERACs and small aggregates in the ER lumen is consistent with previous in vivo and in vitro studies showing
that mutant AVP precursors, resulting from various AVP gene mutations, also accumulated in the ER (Birk
et al., 2009; Ito and Jameson, 1997; Ito et al., 1999; Si-Hoe et al., 2000). In contrast, normal NPII was unde-
tectable in ERACs of FNDI mice. This finding does not exclude the possibility that normal NPII exists in
ERACs, given that the anti-normal NPII antibody PS41 can only detect the normal AVP precursor where
it is sufficiently concentrated. This is supported by the findings in wild-type mice in which PS41 could detect
normal NPII in the dense-core neurosecretory granules but not in the ER.
In this study, we showed that lysosomes were fused to the ERAC membrane and that LAMP2 as well as
cathepsin D were found within ERACs. While previous studies also suggested that a lysosome might be
involved in the degradation of mutant AVP precursor proteins (Castino et al., 2005; Davies and Murphy,
2002), our data suggest that mutant protein aggregates are degraded within the ER by autophagic-lyso-
somal machinery. A clear difference betweenmacro-ER-phagy and ERAC degradation, as shown in the pre-
sent study, is that ERAC degradation occurs in a compartment derived from the ER that maintains connec-
tion to the ER, whereas in macro-ER-phagy, the ER contents are degraded together with the ER itself
following the complete sequestration by phagophores. We showed that aggregates were surrounded
by membranes of high electron density based on SEM. Similarly, a previous study reported that the mem-
branes of phagophores showed high electron density when observed by SBF-SEM, although the compo-
sition of this high density material has yet to be determined (Arai andWaguri, 2019). Our data also revealed
that LC3 was expressed around the aggregates and that rapamycin, which is known to accelerate the for-
mation of phagophores (Vakifahmetoglu-Norberg et al., 2015), increased the degradation of aggregates
surrounded by the membranes. Combined, these data suggest that the membranes possess characteris-
tics of phagophores (Kabeya et al., 2000; Mizushima and Komatsu, 2011; Mizushima et al., 2004) and indi-
cate that ERAC degradation is different to micro-ER-phagy. To the best of our knowledge, this is the first
report showing that accumulated aggregates are degraded within specialized compartments of the ER.
While previous in vitro studies suggested that phagophores originate from the ER (Axe et al., 2008; Graef
et al., 2013; Hamasaki et al., 2013; Hayashi-Nishino et al., 2009; Uemura et al., 2014), our data clearly show
that this is also the case for the phagophore-like membrane surrounding ERACs to which the lysosomes
fuse to form the autolysosome-like structures.
SBF-SEM analyses suggested that lysosomes were fused to the ERACs via ERAC protrusions in some AVP
neurons. Given that not only protein aggregates but also the lysosomal acid hydrolase cathepsin D is local-
ized exclusively in ERACs, some mechanisms should exist by which protein aggregates and lysosome-
relatedmolecules are confined to ERACs in order to protect the remainder of the intact ER lumen. The elec-
tron-lucent areas shown in the electron microscopic analyses have also been observed in our previous
studies (Hayashi et al., 2009). Here, we showed that BiP is expressed in these electron-lucent areas.
Thus, it is possible that molecules related to ERAC formation and confinement of aggregates as well as
lysosomal acid hydrolases to the ERACs might be present in this region, although further studies are
required to clarify the underlying mechanisms.
We previously reported that macroautophagy or cell death was not observed as long as mutant NPII was




Articleformation was disrupted and mutant NPII aggregates were spread throughout the ER lumen after intermit-
tent water deprivation, leading to autophagy-associated cell death of AVP neurons in FNDI mice (Hagiwara
et al., 2014, 2019). Taken together, it seems that ERAC formation as well as degradation of mutant proteins
within ERACs is essential for protecting AVP neurons from cell death in FNDI.
In general, misfolded or unfolded proteins in the ER are targeted for ERAD, in which substrates are trans-
located from the ER to the cytosol and degraded by UPS (Guerriero and Brodsky, 2012; Qi et al., 2017;
Smith et al., 2011). In AVP neurons, wild-type AVP precursors are reported to undergo proteasomal degra-
dation (Friberg et al., 2004). Furthermore, a recent study demonstrated that deficiency of the Sel1L-Hrd1
protein complex, a principal ER-resident E3 ligase in mammalian ERAD, caused marked retention and ag-
gregation of wild-type AVP precursors in the ER, resulting in polyuria due to AVP deficiency (Shi et al., 2017).
While these findings indicate that ERAD is essential to the cellular function of AVP neurons, our present
data showed that, in addition to ERAD, there exists another mechanism by which protein aggregates could
be degraded without translocation from the ER to the cytosol in AVP neurons.
In conclusion, our data demonstrate that mutant proteins undergo autophagic-lysosomal degradation
within ERACs, without isolation or translocation from the ER, in AVP neurons of FNDI mice.
Limitations of the Study
It is unclear from this study how aggregates and lysosomal acid hydrolases are confined to the ERACs.
Furthermore, the roles of the protrusions in the ERACs and the electron-lucent areas around the aggre-
gates also remain to be determined.
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Figure S1. Luminal connections between ERACs and the intact ER in AVP neurons of 
FNDI mice, Related to Figure 2 
The 3D reconstructed ERAC (A, red) and intact ER (A, blue) was cut at the plane of two 
angularly connected electron microscopic images (A) in order to observe the connection 
between an ERAC and the intact ER shown in Figure 2B. The cutting plane is shown as 
a montage image of the two angularly connected electron microscopic images (B-D), one 
of which corresponds to an obliquely cut slice montaged from the original SBF-SEM 
images. In the cutting plane image, the connecting line of the two electron microscopic 
images is shown as an orange line (B), and the luminal areas are colored red (D) to show 






Figure S2. An ERAC containing a relatively small amount of aggregates which fuses with 
lysosomes in AVP neurons of FNDI mice, Related to Figure 2 
(A-D) Serial images of an ERAC containing a relatively small amount of aggregates (A1-
9, red) and its 3D reconstruction (B) show connections (A1 and 2, arrowhead) with the 
intact ER (A1 and 2, blue) and the fusion (A6 and 8, white arrowheads) with lysosomes 
(A6 and 8, purple). Serial images of another ERAC containing a relatively small amount 
of aggregates (C1-6, red) and its 3D reconstruction (D) show the fusion (C1-6, white 
arrowheads) with a lysosome (C1-6, purple). The numbers in the upper-right corners show 
the respective slice number within the electron microscopic image stack. Scale bars: 500 




Figure S3. Ultrastructural localization of normal NPII and BiP in AVP neurons of wild-
type mice, Related to Figures 3 and 4 
(A-E) Immunoelectron microscopic analysis of BiP (10 nm gold particles, black 
arrowheads) and normal NPII (15 nm gold particles, white arrowheads) in AVP neurons 
of the SON (A-C) and in the posterior pituitary (D and E) of wild-type mice. BiP-
immunoreactivity is associated with the membranous structures of rough ER (B) and 
normal NPII is found in neurosecretory vesicles (C). Higher magnification images of the 
boxed areas in A and D are shown in B, C, and E, respectively. Scale bars: 500 nm (A and 




Figure S4. Ultrastructural localization of BiP in the intact ER in AVP neurons of FNDI 
mice, Related to Figure 4 
Immunoelectron microscopic analysis for BiP (10 nm gold particles) in AVP neurons 
showed that BiP-immunoreactivity is associated with the membranous structures of rough 




Figure S5. Localization of GFP in AVP neurons of GFP-LC3 mice, Related to Figure 4 
(A-C) Immunofluorescence staining for GFP-LC3 (green) and normal NPII (magenta) in 
the SON of GFP-LC3 mice. Higher magnification images of the boxed areas in the left 




Figure S6. Localization of LAMP2 or cathepsin D in AVP neurons of wild-type mice, 
Related to Figure 5 
(A-F) Immunofluorescence staining for normal NPII (green) and LAMP2 or cathepsin D 
(magenta) in the SON of wild-type mice. Higher magnification images of the boxed areas 





Figure S7. LC3 conversion (LC3-Ⅰ to LC3-Ⅱ) in the hypothalamus of wild-type mice 
treated with the autophagy inducer rapamycin or the lysosome inhibitor chloroquine, 
Related to Figure 6 
(A and B) Representative immunoblot of protein lysates from the hypothalamus of wild-
type mice in the control and rapamycin (Rapa, A) or chloroquine (CQ, B) groups 
immunolabeled for LC3. The adjacent bar graph displays the ratio of LC3II/LC3I 
densitometric signals relative to that of control mice. Results are expressed as means ± 







FNDI mice heterozygous for the mutant Avp gene (Cys98stop) were generated 
previously (Hayashi et al., 2009). All FNDI mice in the present study were backcrossed 
over 15 generations onto the C57BL/6J background. C57BL/6J mice were purchased 
from Chubu Science Materials (Nagoya, Japan). GFP-LC3 transgenic mice (strain GFP-
LC3#53) harboring a rat LC3-enhanced GFP fusion construct under the control of the 
chicken -actin promoter with the cytomegalovirus immediate early enhancer 
(Mizushima et al., 2004) were obtained from the RIKEN BioResource Center (Tsukuba, 
Japan). FNDI mice were crossed with GFP-LC3 transgenic mice to generate FNDI/GFP-
LC3 mice. Mice were maintained under controlled conditions (23.0 ± 0.5°C, lights on 
09:00 to 21:00), and male mice were used in the experiments. All procedures were 
approved by the Animal Experimentation Committee of the Nagoya University Graduate 
School of Medicine and performed in accordance with institutional guidelines for animal 
care and use. 
 
Brain collection for immunohistochemistry 
Three-month-old male FNDI mice, their wild-type littermates, FNDI/GFP-LC3 mice, 
and GFP-LC3 mice were deeply anesthetized and transcardially perfused with a cold 
fixative containing 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (pH 7.4). After 
fixation, brains were immediately removed and immersed in the same fixative for 3 h at 
4°C. Brains were kept in PBS containing 10-20% sucrose at 4°C for cryoprotection. They 
were then embedded in Tissue-Tek O.C.T. compound (Sakura Finetechnical, Tokyo, 
 
Japan) and stored at −80°C until sectioning. Brains were cut into 16-m sections on a 
cryostat at −20°C, thaw-mounted on Superfrost Plus microscope slides (Matsunami Glass 
Ind., Osaka, Japan), and stored at −80°C until immunohistochemical analysis. 
 
Antibodies 
Primary antibodies used for immunofluorescence staining in the current study 
included: rabbit anti-mutant NPII (Cys98stop) (Hayashi et al., 2009), mouse anti-normal 
NPII (PS41; kindly provided by Dr. H Gainer, National Institutes of Health, Bethesda, 
MD, USA) (Ben-Barak et al., 1984; Ben-Barak et al., 1985), rabbit anti-BiP (#ab21685; 
Abcam, Cambridge, UK), rat anti-LAMP2 (#ab13524; Abcam), goat anti-cathepsin D 
(#sc6486; Santa Cruz Biotechnology, Dallas, TX, USA), and chicken anti-GFP 
(#ab13970; Abcam). The following secondary antibodies were used: Alexa Fluor 488-
conjugated donkey anti-rabbit IgG (H+L) highly cross-adsorbed (#A-21206; Invitrogen, 
San Diego, CA, USA), Alexa Fluor 488-conjugated goat anti-chicken IgY (H+L) (#A-
11039; Invitrogen), Alexa Fluor 488-conjugated donkey anti-mouse IgG (H+L) highly 
cross-adsorbed (#A-21202; Invitrogen), Alexa Fluor 546-conjugated donkey anti-mouse 
IgG (H+L) highly cross-adsorbed (#A-11036; Invitrogen), Alexa Fluor 546-conjugated 
F(ab’)2-goat anti-rabbit IgG (H+L) cross-adsorbed (#A-11071; Invitrogen), Alexa Fluor 
546-conjugated goat anti-rat IgG (H+L) cross-adsorbed (#A-11081; Invitrogen), and 
Alexa Fluor 546-conjugated donkey anti-goat IgG (H+L) cross-adsorbed (#A-11056; 
Invitrogen). Nuclei were stained with DAPI (#340-07971; DOJINDO, Kumamoto, Japan). 
 
Immunohistochemistry 
Frozen sections were washed with PBS for 15 min and then incubated with rabbit anti-
 
mutant NPII antibody (1:1000) in PBS with 0.3% Triton X-100 and 1% normal goat 
serum overnight at 4°C. After rinsing the sections with PBS, the primary antibody was 
probed using biotinylated goat anti-rabbit IgG (H+L) (1:200, #BA-1000; Vector 
Laboratories, Burlingame, CA, USA) for 3 h at room temperature. The sections were 
washed in PBS and then incubated with avidin-biotin complex solution (1:100, Vectastain 
ABC kit, #PK-4000; Vector Laboratories) for 90 min at room temperature before 
immersion in PBS containing 0.1% 3,3’-diaminobenzidine dihydrochloride (Sigma-
Aldrich, St. Louis, MO, USA). Antibody-binding sites were visualized upon addition of 
0.004% hydrogen peroxide. The number and diameter of inclusion bodies in the SON 
were measured using an Olympus DP73 digital camera system and an Olympus BX51 
microscope equipped with cellSens Software (Olympus, Tokyo, Japan). The best-
matched slices at 0.70 mm caudal from the bregma, according to the brain atlas [The 
Mouse Brain in Stereotaxic Coordinates, Academic Press, New York, 2000.], were 
selected from each mouse for analysis. The number of inclusion bodies per SON were 
counted, and the mean values for each mouse were subjected to statistical analyses. Five 
to seven mice per group were used for this analysis. For immunofluorescence staining, 
sections were incubated with these primary antibodies - rabbit anti-mutant NPII (1:1000), 
mouse anti-normal NPII (1:100), rat anti-LAMP2 (1:100), goat anti-cathepsin D (1:100) 
and chicken anti-GFP (1:10000) - overnight at 4 °C. The sections were then treated with 
a 1:1000 dilution of secondary antibodies for 1 h at room temperature. For double-
immunofluorescence staining using the same host primary antibodies, rabbit anti-BiP and 
mutant NPII antibodies, sections were first incubated with rabbit anti-BiP antibody 
(1:600) overnight at 4°C and treated with Alexa Fluor 546-conjugated F(ab’)2-goat anti-
rabbit IgG (H+L) cross-adsorbed (1:100) for 1 h at room temperature. After washing in 
 
PBS, the sections were next incubated with rabbit anti-mutant NPII antibody (1:2000) 
overnight at 4°C and treated with Alexa Fluor 488-conjugated donkey anti-rabbit IgG 
(H+L) highly cross-adsorbed (1:2000) for 1 h at room temperature. Fluorescence images 
were acquired with a laser-scanning confocal microscope (TiEA1R; Nikon Instech, Tokyo, 
Japan) or a fluorescence microscope (BZ-9000; Keyence, Osaka, Japan) and processed 
using Adobe Photoshop CS5 (Adobe Systems, San Jose, CA, USA). Three mice per 
experiment were used for the immunofluorescence analyses. 
 
SBF-SEM 
SBF-SEM analyses were performed as described previously with slight modifications 
(Matsumoto et al., 2019). Briefly, three-month-old male FNDI mice were deeply 
anesthetized and transcardially perfused with 4% PFA and 2.5% glutaraldehyde in 0.1 M 
phosphate buffer (pH 7.4). After fixation, brains were immediately removed and 
immersed overnight at 4°C in the same fixative. Brains were cut into 100-m sections on 
a Vibratome (VT1200 S; Leica Biosystems, Wetzlar, Germany). Tissues were treated with 
2% OsO4 in 1.5% K4[Fe(CN)6] for 1 h at 4℃, and subsequently 1% thiocarbohydrazide 
for 20 min, and 2% OsO4 for 30 min at room temperature. Thereafter, the tissues were 
treated with 1% uranyl acetate at 4℃ overnight and lead aspartate solution for 30 min at 
65℃. The tissues were dehydrated in a graded series of ethanol (60, 80, 90, 95%), treated 
with dehydrated acetone, and embedded in Durcupan resin containing Ketjen black 
powder (5%) for 48 h at 60℃ to ensure polymerization. SBF-SEM for the SON was 
performed using a SigmaVP scanning electron microscope (Carl Zeiss) equipped with a 
3View in-chamber ultramicrotome system (Gatan). Serial image sequences were 
generated at 50-nm steps at a resolution of 4.8-5.7 nm per pixel. Sequential images were 
 
processed with FIJI. Segmentation and three-dimensional reconstruction were performed 
using Microscopy Image Browser (http://mib.helsinki.fi) (Belevich et al., 2016) and 
Amira software (FEI Visualization Science Group, Hillsboro, OR, USA). Two mice were 
used for the SBF-SEM analyses. 
 
Post-embedding immunoelectron microscopy 
Three-month-old male FNDI mice, their wild-type littermates, and FNDI/GFP-LC3 
mice were deeply anesthetized and transcardially perfused with 4% PFA and 0.1% 
glutaraldehyde in 0.1 M phosphate buffer (pH 7.4). Brains and neurohypophyses were 
immediately removed and immersed in the same fixative for 3 h at room temperature or 
overnight at 4ºC. Preparations were dehydrated through increasing concentrations of 
methanol, embedded in LR Gold resin (Electron Microscopy Sciences, PA, USA), and 
polymerized under UV lamps at –20ºC for 24 h. Ultrathin sections (70 nm in thickness) 
were collected on nickel grids coated with a collodion film, rinsed with PBS several times, 
then incubated with 2% normal goat serum and 2% BSA in 50 mM Tris(hydroxymethyl)-
aminomethane-buffered saline (TBS; pH 8.2) for 30 min to block non-specific binding. 
The sections from FNDI mice were then incubated with either a 1:1,000 dilution of rabbit 
anti-mutant NPII antibody or a 1:60 dilution of rabbit anti-BiP antibody and a 1:200 
dilution of mouse anti-normal NPII antibody (Castel et al., 1986) for 1 h at room 
temperature in the blocking solution. The sections were then washed with PBS, then 
incubated with a 1:50 dilution of a goat antibody against rabbit IgG conjugated to 10 nm 
gold particles (BBI Solutions, Cardiff, UK) and a goat antibody against mouse IgG 
conjugated to 15 nm gold particles (BBI Solutions) for 1 h at room temperature. The rat 
anti-LAMP2 antibody or the goat anti-cathepsin D antibody was also used both at 1:20 
 
overnight at 4ºC in Can Get Signal Solution 1 (Toyobo, Tokyo, Japan). After the sections 
were washed with PBS, then incubated with a 1:50 dilution of either a goat antibody 
against rat IgG conjugated to 10 nm gold particles (Sigma, St. Louis, MO, USA) or a 
rabbit antibody against goat IgG conjugated to 10 nm gold particles (BBI Solutions) for 
1 h at room temperature, respectively. To detect the GFP signals in tissues from 
FNDI/GFP-LC3 mice, the sections were incubated with a 1:20 dilution of rabbit anti-GFP 
antibody (Cell Signaling Technology Japan, Tokyo, Japan) for detection of GFP antigens 
to intensify the GFP-LC3 signal (for subcellular localization of LC3) for 1 h at room 
temperature. The immunoreactivity was detected with a streptavidin-biotin kit (Nichirei, 
Tokyo, Japan), followed by incubation with a 1:50 dilution of a goat antibody against 
horseradish peroxidase conjugated to 12 nm gold particles (Jackson ImmunoResearch 
Laboratory, PA, USA) for 1 h at room temperature. Finally, the sections were contrasted 
with uranyl acetate and lead citrate and viewed using an H-7650 (Hitachi, Tokyo, Japan) 
electron microscope operated at 80 kV. Three mice per experiment were used for the 
immunoelectron microscopic analyses. 
 
Rapamycin and chloroquine administration 
Two-month-old male FNDI mice and their wild-type littermates were divided into 
control and rapamycin or chloroquine groups. FNDI mice in the rapamycin or 
chloroquine groups were treated with an intraperitoneal administration of rapamycin (20 
mg/kg/day, #R-5000, LC Laboratories, Woburn, MA, USA) or chloroquine (20 
mg/kg/day, #C6628, Sigma-Aldrich) daily for 28 days, in addition to wild-type littermates 
for 7 days. The dosage of rapamycin or chloroquine employed in this study was 
determined based on previous studies (Cortes et al., 2012; Nalbandian et al., 2015; 
 
Ravikumar et al., 2004; Vodicka et al., 2014; Zois et al., 2011). 
 
Immunoblotting 
The hypothalamus of wild-type mice were lysed in a buffer containing 10 mM Tris-
HCl pH 7.4, 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 5 
mM EDTA, 50 mM NaF, 2 mM Na3VO4, and 1% protease inhibitor cocktail (Sigma-
Aldrich). After centrifuging the samples, protein concentrations in the supernatants were 
determined by bicinchoninic acid assay using a bicinchoninic acid kit (Sigma-Aldrich). 
Ten micrograms of protein per sample was separated by 10% SDS-PAGE and transferred 
to polyvinylidene difluoride membranes (Millipore). Blots were blocked in 5% skimmed 
milk in TBS-T solution (10 mM Tris-HCl pH 7.4, 150 mM NaCl and 0.1% Tween) for 1 
h at RT. Membranes were incubated with a mouse anti-LC3 antibody (1:10000, #M186-
3; Medical and Biological Laboratories, Nagoya, Japan) overnight at 4℃ and a rabbit 
anti--actin antibody (1:10000, #ab8227; Abcam) for 1 h at RT. Primary antibodies were 
probed with HRP-conjugated goat anti-mouse IgG (1:10000, #P0447; Agilent, Tokyo, 
Japan) and HRP-conjugated donkey anti-rabbit IgG (1:10000, #NA934; GE Healthcare, 
Little Chalfont, UK) for 1 h at RT. To improve sensitivity and the signal-to-noise ratio, 
Can Get Signal Immunoreaction Enhancer Solution (Toyobo) was used for the dilution of 
the primary and secondary antibodies. Immunoreactivity was detected using the ECL 
Prime Western Blotting Detection Reagent (GE Healthcare). Blots were quantified using 
NIH ImageJ software. Four mice per group were used for the immunoblotting analyses. 
 
Statistical analysis 
Statistical significance of the differences among groups was analyzed by an unpaired 
 
t-test. Results are expressed as means ± SE, and differences were considered statistically 
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